Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles.
Mezzaroba N, Zorzet S, Secco E, Biffi S, Tripodo C, Calvaruso M, Mendoza-Maldonado R, Capolla S, Granzotto M, Spretz R, Larsen G, Noriega S, Lucafò M, Mansilla E, Garrovo C, Marín GH, Baj G, Gattei V, Pozzato G, Núñez L, Macor P. Mezzaroba N, et al. Among authors: capolla s. PLoS One. 2013 Sep 30;8(9):e74216. doi: 10.1371/journal.pone.0074216. eCollection 2013. PLoS One. 2013. PMID: 24098639 Free PMC article.
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice.
Macor P, Secco E, Mezzaroba N, Zorzet S, Durigutto P, Gaiotto T, De Maso L, Biffi S, Garrovo C, Capolla S, Tripodo C, Gattei V, Marzari R, Tedesco F, Sblattero D. Macor P, et al. Among authors: capolla s. Leukemia. 2015 Feb;29(2):406-14. doi: 10.1038/leu.2014.185. Epub 2014 Jun 6. Leukemia. 2015. PMID: 24903480 Free article.
Complement as a Biological Tool to Control Tumor Growth.
Macor P, Capolla S, Tedesco F. Macor P, et al. Among authors: capolla s. Front Immunol. 2018 Sep 25;9:2203. doi: 10.3389/fimmu.2018.02203. eCollection 2018. Front Immunol. 2018. PMID: 30319647 Free PMC article. Review.
Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell Lymphoma.
Belmonte B, Cancila V, Gulino A, Navari M, Arancio W, Macor P, Balduit A, Capolla S, Morello G, Vacca D, Ferrara I, Bertolazzi G, Balistreri CR, Amico P, Ferrante F, Maiorana A, Salviato T, Piccaluga PP, Mangogna A. Belmonte B, et al. Among authors: capolla s. Cancers (Basel). 2021 Jun 12;13(12):2958. doi: 10.3390/cancers13122958. Cancers (Basel). 2021. PMID: 34204843 Free PMC article.
17 results